Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Mar 31, 2016 8:03:27 GMT -5
For those of you who do not receive the "Insulin News" email from Sanofi, I had a nice email in my inbox this morning. "Hi Scott, As you may have seen in public media communications, Afrezza® will be transferred back from Sanofi to MannKind Corporation on April 4, 2016. Future communications to you on Afrezza may come from MannKind Corporation. In addition, you may continue to receive diabetes and other health related communications from Sanofi. From April 5, 2016 onwards all questions regarding Afrezza should be directed to MannKind Corporation at 1-877-323-8505 or you can visit www.Afrezza.com." So we are on track for the timeline to return Afrezza. For now, cash is king. Matt did not sound concerned during the last call. Hopefully Matt can share some good news shortly. Pfizer gave Nectar $135mm when they discontinued Exubera. I don't believe Sanofi won't pay that kind of money to Mannkind but time will tell. |
|
|
|
Post by coo2002coo on Mar 31, 2016 8:21:59 GMT -5
Just wonder who else here has received the same.
|
|
|
|
Post by mindovermatter on Mar 31, 2016 8:29:01 GMT -5
For those of you who do not receive the "Insulin News" email from Sanofi, I had a nice email in my inbox this morning. "Hi Scott, As you may have seen in public media communications, Afrezza® will be transferred back from Sanofi to MannKind Corporation on April 4, 2016. Future communications to you on Afrezza may come from MannKind Corporation. In addition, you may continue to receive diabetes and other health related communications from Sanofi. From April 5, 2016 onwards all questions regarding Afrezza should be directed to MannKind Corporation at 1-877-323-8505 or you can visit www.Afrezza.com." So we are on track for the timeline to return Afrezza. For now, cash is king. Matt did not sound concerned during the last call. Hopefully Matt can share some good news shortly. Pfizer gave Nectar $135mm when they discontinued Exubera. I don't believe Sanofi won't pay that kind of money to Mannkind but time will tell. Matt also stated they were happy with Sanofi while all along he knew things were going to unravel. Taking a CEOs word can be a very dangerous thing to an investor. It is more important that this failing company SHOWS us rather than tells us as it has very little success in proving it can execute successfully. And I apologize in advance to those who get emotionally hurt by straight forward facts. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Mar 31, 2016 8:36:38 GMT -5
Mindovermatter, fair enough. Trust but verify. How do you suppose they got the new guy to join them from Amgen? Either they demonstrated to him that they have a viable plan and/or guaranteed cash should things not work out or he was in the process of leaving or had already left Amgen and signing on to Mannkind presented no risk.
|
|
|
|
Post by saxcmann on Mar 31, 2016 8:37:52 GMT -5
For those of you who do not receive the "Insulin News" email from Sanofi, I had a nice email in my inbox this morning. "Hi Scott, As you may have seen in public media communications, Afrezza® will be transferred back from Sanofi to MannKind Corporation on April 4, 2016. Future communications to you on Afrezza may come from MannKind Corporation. In addition, you may continue to receive diabetes and other health related communications from Sanofi. From April 5, 2016 onwards all questions regarding Afrezza should be directed to MannKind Corporation at 1-877-323-8505 or you can visit www.Afrezza.com." So we are on track for the timeline to return Afrezza. For now, cash is king. Matt did not sound concerned during the last call. Hopefully Matt can share some good news shortly. Pfizer gave Nectar $135mm when they discontinued Exubera. I don't believe Sanofi won't pay that kind of money to Mannkind but time will tell. Matt also stated they were happy with Sanofi while all along he knew things were going to unravel. Taking a CEOs word can be a very dangerous thing to an investor. It is more important that this failing company SHOWS us rather than tells us as it has very little success in proving it can execute successfully. And I apologize in advance to those who get emotionally hurt by straight forward facts. Straight forward facts??!....lol |
|
|
|
Post by mindovermatter on Mar 31, 2016 9:00:53 GMT -5
Mindovermatter, fair enough. Trust but verify. How do you suppose they got the new guy to join them from Amgen? Either they demonstrated to him that they have a viable plan and/or guaranteed cash should things not work out or he was in the process of leaving or had already left Amgen and signing on to Mannkind presented no risk. People like challenges and new opportunities. No one knows if he was Mannkind's first choice and how many applied in the first place. And nothing is guaranteed in business or in stock investment. How many here thought Mannkind would be in this position at this date and time? I am sure if those of you were polled a year back, not one of you would have said Mannkind would be in the position it is right now. Statistically, odds of success are not great especially in the cut throat pharma industry. One can only hope that Mannkind gets it right this time because it is their last shot. |
|
|
|
Post by nylefty on Mar 31, 2016 10:35:44 GMT -5
So we are on track for the timeline to return Afrezza. For now, cash is king. Matt did not sound concerned during the last call. Hopefully Matt can share some good news shortly. Pfizer gave Nectar $135mm when they discontinued Exubera. I don't believe Sanofi won't pay that kind of money to Mannkind but time will tell. Matt also stated they were happy with Sanofi while all along he knew things were going to unravel. Taking a CEOs word can be a very dangerous thing to an investor. It is more important that this failing company SHOWS us rather than tells us as it has very little success in proving it can execute successfully. And I apologize in advance to those who get emotionally hurt by straight forward facts. Mindovermatter: Do you actually own any MannKind stock? If so, why don't you get out of what you consider a "failing company" before it drops to the level your fellow-basher, Jay Olson, is predicting (5 cents)? |
|
|
|
Post by sf1981 on Mar 31, 2016 11:14:23 GMT -5
Matt also stated they were happy with Sanofi while all along he knew things were going to unravel. Taking a CEOs word can be a very dangerous thing to an investor. It is more important that this failing company SHOWS us rather than tells us as it has very little success in proving it can execute successfully. And I apologize in advance to those who get emotionally hurt by straight forward facts. Mindovermatter: Do you actually own any MannKind stock? If so, why don't you get out of what you consider a "failing company" before it drops to the level your fellow-basher, Jay Olson, is predicting (5 cents)? Why are some of you so childish as to immediately insult anyone who puts forth a negative fact? This was a perfectly valid point to be made. Matt has twisted the truth many many times. It is understandable why, but it still hasn't been straight talk. Take off the rose-coloured glasses, for God's sake! |
|
|
|
Post by nylefty on Mar 31, 2016 11:20:42 GMT -5
Mindovermatter: Do you actually own any MannKind stock? If so, why don't you get out of what you consider a "failing company" before it drops to the level your fellow-basher, Jay Olson, is predicting (5 cents)? Why are some of you so childish as to immediately insult anyone who puts forth a negative fact? This was a perfectly valid point to be made. Matt has twisted the truth many many times. It is understandable why, but it still hasn't been straight talk. Take off the rose-coloured glasses, for God's sake! Mindovermatter puts forth nothing but "negative facts." My post wasn't about Matt. It was about Mindovermatter's incessant bashing. |
|
|
|
Post by LosingMyBullishness on Mar 31, 2016 11:35:33 GMT -5
Mindovermatter: Do you actually own any MannKind stock? If so, why don't you get out of what you consider a "failing company" before it drops to the level your fellow-basher, Jay Olson, is predicting (5 cents)? Why are some of you so childish as to immediately insult anyone who puts forth a negative fact? This was a perfectly valid point to be made. Matt has twisted the truth many many times. It is understandable why, but it still hasn't been straight talk. Take off the rose-coloured glasses, for God's sake! sf, Reason could be that this is not the first negative statement from mind. I invite you to read up his last comments and posts. Concerning his 'fact': he argued that Matt can not be trusted as he did not disclose during the partnership with SNY that MNKD is unhappy about SNY's marketing, pricing etc. The fact is that MNKD was and is unhappy about SNY did marketing and pricing. What is not a fact but a spin is that Matt can not be trusted as he did not disclose this. Mind creates a connection that factually does not exist. Why: How many partnership in business do you know where one partner publicly states that he is unhappy about it. There is none. They sort this out behind closed door or separate. So Matt should not have been trusted if he had publicly criticised SNY as this is not standard business practice and most probably against contract. So in both scenarios Matt can not be trusted...classic FUD stuff. |
|
